Loading...
Chemical structure of Neurodegenerative Disorder-Targeting Compound 1

GC31311

Neurodegenerative Disorder-Targeting Compound 1

Also known as 1-benzyl-N-[3,4-dioxo-1-phenyl-4-(pyridin-2-ylmethylamino)butan-2-yl]-5-oxopyrrolidine-2-carboxamide

Neurodegenerative Disorder-Targeting Compound 1 is a calpain inhibitor (extracted from patent WO2010128102A1, compound 63)

ChemicalCAS1254699-12-1MW484.55FormulaC28H28N4O4
CAS number
1254699-12-1
Molecular weight
484.55
Formula
C28H28N4O4
Solubility
Soluble in DMSO
InChIKey
VBRYNLHJJUQPDB-UHFFFAOYSA-N
Catalogue number
GC31311
Brand
GLPBIO
Computed properties PubChem CID 49785360 · XLogP 2.3 · TPSA 108 Ų · H-bond donors 2
XLogP
2.3
TPSA
108 Ų
H-bond donors
2
H-bond acceptors
5
Rotatable bonds
10
Heavy atoms
36

SMILES C1CC(=O)N(C1C(=O)NC(CC2=CC=CC=C2)C(=O)C(=O)NCC3=CC=CC=N3)CC4=CC=CC=C4

Computed descriptors from PubChem (CID 49785360), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.